Enlarge DeFodi Images Late Friday, the Food and Drug Administration issued an emergency authorization to a COVID-19 vaccine from a company called Moderna. The move follows an enthusiastic endorsement of the vaccine following an evaluation of clinical trial data by the FDA’s Vaccines and Related Biological Products Advisory Committee. Moderna already has millions of doses …
Enlarge / Protests by medical staff took place both inside and out of the hospital. Ars Technica Update, 10:00pm EST: Stanford Medicine shared the following statement with Ars: “We take complete responsibility for the errors in the execution of our vaccine distribution plan. Our intent was to develop an ethical and equitable process for distribution …
Stanford hospital erupts in protest after vaccine plan leaves out residents [UPDATED] Read More »
Enlarge Ellume The FDA’s ability to issue Emergency Use Authorizations isn’t limited to treatments; the administration can also hand them out for medical equipment and tests. And today, it approved the first over-the-counter, at-home SARS-CoV-2 test kit. The kit detects the presence of a protein found on the surface of the virus and sends the …
FDA authorizes use of a nonprescription home COVID test Read More »
Enlarge DeFodi Images As the first doses of the Pfizer/BioNTech vaccine were administered yesterday, most of the US public began a potentially long waiting game, as the vaccine will be in short supply for many months and is being administered to healthcare workers and the elderly first. For most of the US, that means waiting …
FDA releases data on Moderna’s COVID vaccine: It looks good [Updated] Read More »
Enlarge / An illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer, on November 17, 2020. Getty | JUSTIN TALLIS The COVID-19 vaccine developed by Pfizer and BioNTech should be granted an Emergency Use Authorization from the US Food and Drug Administration, according to a committee of …
FDA advisors give thumbs up to Pfizer vaccine, paving way for authorization Read More »
Enlarge / Vials in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020. Getty| NurPhoto Pharmaceutical giant AstraZeneca and the University of Oxford made an exciting announcement Monday: the COVID-19 vaccine they developed together appeared up to 90 percent effective at preventing disease. But in …
AstraZeneca’s best COVID vaccine result was a fluke. Experts have questions Read More »
Enlarge / Students have their temperature measured at Daowu middle school in China’s Hunan Province, part of the measures adopted to limit the spread of the coronavirus. Xinhua News Agency Early on in the COVID-19 pandemic, there were a lot of big questions about the basic properties of SARS-CoV-2: how quickly did it spread, could …
What we can learn from contact tracing an entire province Read More »
Enlarge / Vials in front of the AstraZeneca British biopharmaceutical company logo are seen in this creative photo taken on 18 November 2020. Getty| NurPhoto AstraZeneca announced in a press release on Monday that its COVID-19 vaccine showed positive results in an interim analysis of clinical trial data. The announcement marks the third vaccine to show …
AstraZeneca’s COVID-19 vaccine shows success: Here’s how it stacks up to others Read More »
Enlarge / Good luck not getting COVID! GraphicaArtis/Getty Images In a rare press briefing Thursday, experts from the Centers for Disease Control and Prevention strongly urged Americans not to travel for Thanksgiving or gather with people outside of their “households”—defined as only the people actively living together in the 14 days prior to a gathering. …
CDC Thanksgiving guidance: No traveling, no outside-household members Read More »
Enlarge / An illustration picture shows vials with Covid-19 Vaccine stickers attached, with the logo of US pharmaceutical company Pfizer, on November 17, 2020. Getty | JUSTIN TALLIS Pharmaceutical giant Pfizer and German biotech firm BioNTech announced Wednesday that they have wrapped up the Phase III trial of their COVID-19 mRNA vaccine, finding it to …
Pfizer reports final vaccine results: 95% efficacy Read More »
